By summarizing data on HER2, VEGR, EGFR, mTOR, MET, and other common cancer targets or signaling pathways, this review attempts to expound the advance of molecular targeted therapy for gastric cancer in recent years. This evidence concerns the gene ERBB2 and gastric cancer.